Abstract

The main goal of this study was to assess the frequency of effectiveness and the tolerability of therapy in the treatment of severe acne with isotretinoin (Sotret) as monotherapy. In this study, 115 patients with severe acne were examined and treated: 107 (94.69 %) with papulo-pustular acne, 7 (6.19 %) with conglobate acne, and 1 (0.88 %) with keloid acne. Evaluation of the frequency of outcomes in the treatment of severe acne with isotretinoin Sotret was studied based on data obtained during a medical examination, which evaluated the dynamics of changes in the severity of acne according to the classification adopted by the American Academy of Dermatology (AAD, 1990) and based on data from the Assessment of Psychological and Social Effect of Acne (APSEA) Questionnaire.

Highlights

  • The main goal of this study was to assess the frequency of effectiveness

  • Evaluation of the frequency of outcomes in the treatment of severe acne with isotretinoin Sotret was studied based on data obtained during a medical examination

  • which evaluated the dynamics of changes in the severity of acne according to the classification adopted by the

Read more

Summary

Оригинальные статьи

Сотрет: эффективность монотерапии системным изотретиноином при лечении тяжелых форм акне.

Effectiveness of isotretinoin monotherapy in treatment of severe acne
Оценка уровня приверженности монотерапии изотретиноином
Рубцы постакне
Findings
Увеличение дозы Уменьшение дозы
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.